SAN DIEGO, CA – November 6, 2008 BioTox Sciences (BTS), a GLP nonclinical Contract Research Organization (CRO) located in San Diego, CA, announced today that it has been contracted to provide formulation, preclinical, and bioanalytical services to Excaliard Pharmaceuticals.
“BioTox Sciences is pleased to welcome Excaliard Pharmaceuticals into our family of Sponsors,” said Sami Abunadi, President of BioTox Sciences. “We are committed to providing excellence in our preclinical services and hope to establish a long lasting relationship with Excaliard and its team.”
ABOUT BIOTOX SCIENCES
BioTox Sciences, based in San Diego, is a Contract Research Organization (CRO) offering comprehensive services for preclinical and nonclinical studies in a state of the art AAALAC accredited vivarium. Their services encompass toxicology, pharmacology and metabolism testing in support of nonclinical drug development. BTS has a highly trained and experienced staff able to conduct studies under Good Laboratory Practices (GLP) and non-GLP. More information is available at www.BioToxSciences.com
ABOUT EXCALIARD PHARMACEUTICALS, INC.
Excaliard is a biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases. Excaliard has a licensed patented, clinically proven technology with multiple therapeutic opportunities in fibrosis. On the basis of extensive pre-clinical data with this technology, Excaliard anticipates early proof of concept in man. More information is available at www.Excaliard.com SOURCE: BioTox Sciences Press Release / Story Excaliard Pharmaceuticals Contracts BioTox Sciences for Preclinical Research Services URL N/A First Name Brian Last Name Perkins Email info@BioToxSciences.com
